Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 25, 2000
Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: relationship to TAP expression
J L Murray, J M Hudson, M I Ross, et al.
Archives of Neurology
|
May 1, 1984
Facioscapulohumeral dystrophy associated with multiple sclerosis
S K Mishra, R D Currier, E E Smith, et al.
Cancer Immunology, Immunotherapy : CII
|
September 29, 1999
HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells
L D Anderson, J M Hudson, C A Savary, et al.
Environmental Science & Technology
|
May 24, 2008
Characterization of methyl mercury in dental wastewater and correlation with sulfate-reducing bacterial DNA
Xiuhong Zhao, Karl J Rockne, James L Drummond, et al.
Anticancer Research
|
January 1, 1997
Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides
B Fisk, J M Hudson, J Kavanagh, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction
B Fisk, C Savary, J M Hudson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 26, 1998
Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer
J M Hudson, A Castilleja, J L Murray, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 25, 2000
Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: relationship to TAP expression
J L Murray, J M Hudson, M I Ross, et al.
Archives of Neurology
|
May 1, 1984
Facioscapulohumeral dystrophy associated with multiple sclerosis
S K Mishra, R D Currier, E E Smith, et al.
Cancer Immunology, Immunotherapy : CII
|
September 29, 1999
HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells
L D Anderson, J M Hudson, C A Savary, et al.
Environmental Science & Technology
|
May 24, 2008
Characterization of methyl mercury in dental wastewater and correlation with sulfate-reducing bacterial DNA
Xiuhong Zhao, Karl J Rockne, James L Drummond, et al.
Anticancer Research
|
January 1, 1997
Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides
B Fisk, J M Hudson, J Kavanagh, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction
B Fisk, C Savary, J M Hudson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 26, 1998
Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer
J M Hudson, A Castilleja, J L Murray, et al.
Page
of 3